Similar articles

• Increasing transplanted cell survival with cell-based angiogenic gene therapy.

  Yau TM, Kim C, Ng D, Li G, Zhang Y, Weisel RD, Li RK. Yau TM, et al. Ann Thorac Surg. 2005 Nov;80(5):1779-86. doi: 10.1016/j.athoracsur.2005.04.079. Ann Thorac Surg. 2005. PMID: 16242455
• Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair.

  Ye L, Haider HKh, Tan R, Toh W, Law PK, Tan W, Su L, Zhang W, Ge R, Zhang Y, Lim Y, Sim EK. Ye L, et al. Circulation. 2007 Sep 11;116(11 Suppl):I113-20. doi: 10.1161/CIRCULATIONAHA.106.680124. Circulation. 2007. PMID: 17846290
• Cell transplantation for heart disease: the clinical perspective.

  Yang S, Fazel S, Angoulvant D, Weisel RD, Li RK. Yang S, et al. Evid Based Cardiovasc Med. 2005 Mar;9(1):2-7. doi: 10.1016/j.ebcm.2005.01.045. Evid Based Cardiovasc Med. 2005. PMID: 16379977 Review. No abstract available.
• Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.

  Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, Wang YQ, Liu QY, Gao YZ, Mi SH. Rong SL, et al. Chin Med J (Engl). 2008 Feb 20;121(4):347-54. Chin Med J (Engl). 2008. PMID: 18304469
• Stem cells and their potential in cell-based cardiac therapies.

  Christoforou N, Gearhart JD. Christoforou N, et al. Prog Cardiovasc Dis. 2007 May-Jun;49(6):396-413. doi: 10.1016/j.pcad.2007.02.006. Prog Cardiovasc Dis. 2007. PMID: 17498520 Review.